(Q39738825)

14 September 2017

1 reference

title

Clinical pharmacokinetics of disopyramide. (English)

1 reference

14 September 2017

2

1 reference

14 September 2017

L A Siddoway

1

1 reference

14 September 2017

1 May 1986

1 reference

Clinical Pharmacokinetics

14 September 2017

1 reference

14 September 2017

11

1 reference

14 September 2017

214-222

1 reference

14 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198611030-00003

14 September 2017

0 references

cites work

Acute intoxication with diisopyramide: clinical and experimental study by hemoperfusion an Amberlite XAD 4 resin

1 reference

12 December 2020

Placental and milk transfer of disopyramide and metabolites

1 reference

12 December 2020

Effect of ethanol intake on disopyramide elimination by healthy volunteers

1 reference

12 December 2020

Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia

1 reference

12 December 2020

Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment.

1 reference

12 December 2020

Plasma concentration of disopyramide given as capsules and controlled release tablets

1 reference

12 December 2020

Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide

1 reference

12 December 2020

Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog

1 reference

12 December 2020

Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction?

1 reference

12 December 2020

Disopyramide binding to serum protein in man and animals.

1 reference

12 December 2020

Role of concentration-dependent plasma protein binding in disopyramide disposition

1 reference

12 December 2020

The pharmacokinetics of Norpace

1 reference

12 December 2020

Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle

1 reference

12 December 2020

Stereoselective binding of disopyramide to human plasma protein

1 reference

12 December 2020

Disopyramide pharmacokinetics and bioavailability

1 reference

12 December 2020

The cardiac effects of d- and l-disopyramide in normal subjects: a noninvasive study.

1 reference

12 December 2020

Disopyramide concentrations in saliva

1 reference

12 December 2020

Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure

1 reference

12 December 2020

Disopyramide kinetics in patients with acute myocardial infarction

1 reference

12 December 2020

Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide

1 reference

12 December 2020

Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans

1 reference

12 December 2020

The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens

1 reference

12 December 2020

Pharmacokinetics of disopyramide in patients with chronic renal failure

1 reference

12 December 2020

Disopyramide Plasma and Myocardial Tissue Concentrations as They Relate to Antiarrhythmic Activity

1 reference

12 December 2020

Disopyramide: serum level and arrhythmia conversion

1 reference

12 December 2020

Influence of concentration-dependent protein binding on serum concentrations and urinary excretion of disopyramide and its metabolite following oral administration

1 reference

12 December 2020

Plasma binding of disopyramide

1 reference

12 December 2020

Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins

1 reference

12 December 2020

Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration

1 reference

12 December 2020

Effect of altered disopyramide binding on its pharmacologic response in rabbits

1 reference

12 December 2020

The pharmacokinetics of disopyramide in patients with acute myocardial infarction

1 reference

12 December 2020

Some pharmacological effects of disopyramide and a metabolite

1 reference

12 December 2020

Maintenance therapy after i.v. administration of disopyramide with an oral sustained release preparation, a pharmacokinetic study

1 reference

12 December 2020

Disopyramide in pregnancy: a case report

1 reference

12 December 2020

Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients

1 reference

12 December 2020

The influence of protein binding on disopyramide clearance

1 reference

12 December 2020

Comparative bioavailability of disopyramide after multiple dosing with standard capsules and controlled-release tablets

1 reference

12 December 2020

Disopyramide kinetics in renal impairment: determinants of interindividual variability

1 reference

12 December 2020

Quantitative analysis of the disopyramide concentration-effect relationship

1 reference

12 December 2020

Disopyramide pharmacokinetics during recovery from myocardial infarction

1 reference

12 December 2020

Plasma binding of disopyramide and mono-N-dealkyldisopyramide

1 reference

12 December 2020

Species differences in the biotransformation of a new antiarrhythmic agent: disopyramide phosphate

1 reference

12 December 2020

Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability

1 reference

12 December 2020

Plasma disopyramide concentrations following a 300-mg oral loading dose in acute myocardial infarction

1 reference

12 December 2020

Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction

1 reference

12 December 2020

Paediatric use of mexiletine and disopyramide

1 reference

12 December 2020

Plasma concentrations and protein binding of disopyramide and mono-N-dealkyldisopyramide during chronic oral disopyramide therapy

1 reference

12 December 2020

Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.

1 reference

12 December 2020

Disopyramide hemodialysis and kinetics in patients requiring long-term hemodialysis

1 reference

12 December 2020

The Stereoselective Disposition of Disopyramide in the Dog

1 reference

12 December 2020

Effect of age and plasma concentrations of albumin and alpha 1-acid glycoprotein on protein binding of disopyramide

1 reference

12 December 2020

The effect of enzyme induction on the metabolism of disopyramide in man.

1 reference

12 December 2020

The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide

1 reference

12 December 2020

10.2165/00003088-198611030-00003

Identifiers

DOI

1 reference

PubMed ID

3524956

Dimensions Publication ID

14 September 2017

0 references

1 reference

PubMed ID

3524956